Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,229,794 papers from all fields of science
Search
Sign In
Create Free Account
Novoseven
Known as:
Novo Seven
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (3)
Factor VIIa
factor VII
recombinant FVIIa
eptacog alfa activated 0.001 MG Injection [Novoseven]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Surgical resection of a sphenoid wing meningioma in a patient with Glanzmann thrombasthenia.
Damien Wertz
,
P. Boveroux
,
P. Péters
,
J. Lénelle
,
C. Franssen
Acta anaesthesiologica Belgica
2011
Corpus ID: 13637879
Glanzmann thrombasthenia (GT) is a rare autosomal recessive disorder characterized by a deficiency or functional defect of…
Expand
2010
2010
In vitro effects of recombinant activated factor VIIa (NovoSeven) on clopidogrel-induced platelet inhibition
F. Szlam
,
Kenichi A. Tanaka
,
Brady Rumph
,
D. Bolliger
,
J. Levy
Thrombosis and Haemostasis
2010
Corpus ID: 40076712
In vitro effects of recombinant activated factor VIIa (NovoSeven) on clopidogrel-induced platelet inhibition -
2008
2008
The Use of Recombinant Coagulation Factor VIIa (NovoSeven ® ) in Severe Diverticular Bleeding
M. Guenin
,
R. Peterli
,
B. Kern
,
C. Ackermann
2008
Corpus ID: 15275876
We report a 68-year-old man with sigmoid colon carcinoma who previously underwent an anterior resection. Five years later, he…
Expand
2007
2007
An Evaluation of Off-Label Use of Recombinant Activated Human Factor VII (NovoSeven) Patient Characteristics, Utilization Trends, and Outcomes From an Electronic Database of U.S. Academic Health…
S. Magnetti
,
M. Oinonen
,
K. Matuszewski
2007
Corpus ID: 10939138
Background. Recombinant activated factor VII (rFVIIa), which has been approved by the Food and Drug Administration for the…
Expand
2005
2005
[Treatment of life-threatening bleeding in obstetrics and gynaecology --NovoSeven (recombinant factor VIIa)].
A. Nikolov
,
A. Dimitrov
,
+4 authors
A. Gerganova
Akusherstvo i ginekologiia
2005
Corpus ID: 40853871
The study offers the results from the application of recombinant factor VIIa (NovoSeven) in 19 patients with obstetric or…
Expand
2004
2004
Off-Label Use of Recombinant Activated Factor VII (NovoSeven ® )
T. Ratko
,
Joseph P. Cummings
,
K. Matuszewski
2004
Corpus ID: 41970676
NovoSeven® (Novo Nordisk, Denmark) is a recombinant DNA preparation of activated blood coagulation factor VII (rFVIIa). It is…
Expand
2004
2004
[Use of "NovoSeven" (rFVIIa) hemostatic in patients operated with extracorporeal blood circulation].
I. I. Dement’eva
,
V. Sandrikov
,
M. A. Charnaia
,
I. Morozov
,
N. Trekova
,
A. Eremenko
Anesteziologiia i reanimatologiia
2004
Corpus ID: 38727400
The "NovoSeven" drug was used in 25 patients (male - 18, female - 7) operated on the heart and main vessels including with…
Expand
2003
2003
[Using recombinant activated coagulation factor VII (NovoSeven) in obstetrics].
B. Pekhlivanov
,
N. Milchev
,
B. Abrashev
Akusherstvo i ginekologiia
2003
Corpus ID: 7781088
The authors share their experience about the application of the NovoSeven in four cases with different types of hemostasiologic…
Expand
Review
2003
Review
2003
Inhibitor treatment: state of the art.
A. Shapiro
Disease-a-month : DM
2003
Corpus ID: 33688189
The treatment of hemophilic patients with inhibitors presents many challenges. Recombinant activated factor VII (rFVIIa…
Expand
1998
1998
Management of an anti-factor VIII inhibitor occurring during surgical procedure with continuous infusion of Novoseven.
C. Menart
,
V. Cognet
,
P. Petit
,
D. Massignon
,
Claude Negrier
Blood Coagulation and Fibrinolysis
1998
Corpus ID: 38277995